This paper provides a valuable observation that imiquimod, a compound often used to induce a psoriasis-like skin inflammation in mice, has a TLR7-independent effect acting through the unfolded protein ...
Skin remembers. That scar above your eye from when you fell at age 6. That freckle from the summer you turned 13. Our skin is a repository of moments from our lives, and now scientists have found it ...
Johnson & Johnson (J&J) and partner Protagonist have secured FDA approval for icotrokinra (Icotyde), a macrocyclic peptide that targets the IL-23 receptor, for the treatment of plaque psoriasis. J&J ...
"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms were at their worst Nicholas Rice is a Senior News Editor, Weekends for PEOPLE ...
Credit: Johnson & Johnson. Oral icotrokinra is now FDA-approved for plaque psoriasis, offering a new systemic option for adults and adolescents who weigh at least 40kg. Phase 3 clinical trials ...
"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox Patt tells PEOPLE Nicholas Rice is a Senior News Editor, Weekends for PEOPLE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results